Garden Grove-based Hybor Biomedical, which manufactures and markets in vitro diagnostic products for the autoimmune and allergy market, has sold its urinalysis business to an affiliate of One Rock Capital Partners, Laurel Crown Partners, and StoneCreek Capital. Financial terms of the deal were not disclosed. Hycor said that it was advised by Houlihan Lokey and Kirkland & Ellis LLP in the deal. Hycor is backed by Linden Capital Partners.
Top NewsWednesday, February 20, 2013
Hycor Biomedical Sells Unit To Private Equity Firms